The decline in Anavex Life Sciences' stock price is a direct reaction to the Q4 financial results. Typically, when a company reports earnings that are not up to market expectations, its stock price tends to fall as investors adjust their valuation of the company. The immediate negative impact suggests that the results were below analyst expectations or the market's anticipation.